Pretax income is the income that a company earns before paying income taxes. Fresenius SE KGaA's pretax income for the
three
months ended in Mar. 2026 was CHF525 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Mar. 2026 was CHF2,000 Mil.
Fresenius SE KGaA's pretax margin was 9.92%.
During the past 13 years, Fresenius SE KGaA's highest Pretax Margin was 13.91%. The lowest was 3.67%. And the median was 10.00%.
Fresenius SE KGaA (XSWX:FRE) Pre-Tax Income Explanation
Fresenius SE KGaA's Pretax Margin for the quarter that ended in Mar. 2026 is calculated as
During the past 13 years, Fresenius SE KGaA's highest Pretax Margin was 13.91%. The lowest was 3.67%. And the median was 10.00%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA Pre-Tax Income Related Terms
Fresenius SE KGaA Pre-Tax Income Historical Data
* Premium members only.
The historical data trend for Fresenius SE KGaA's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:FRE vs HCA, THC, DVA: Pre-Tax Income Comparison
For the Medical Care Facilities subindustry, Fresenius SE KGaA's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius SE KGaA Pre-Tax Income vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Fresenius SE KGaA's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF2,000 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius SE KGaA (XSWX:FRE) has a Pre-Tax Income of CHF2,000 Mil as of Mar. 2026. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Fresenius SE KGaA and its competitors.
Is Fresenius SE KGaA's Pre-Tax Income too high?
Fresenius SE KGaA's current Pre-Tax Income is CHF2,000 Mil. Overall, Fresenius SE KGaA has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Pre-Tax Income compare to HCA and THC?
Fresenius SE KGaA's Pre-Tax Income of CHF2,000 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Healthcare Providers & Services company?
A good Pre-Tax Income depends on the Healthcare Providers & Services industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Fresenius SE KGaA and its competitors. Fresenius SE KGaA's current Pre-Tax Income is CHF2,000 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Fresenius SE KGaA (XSWX:FRE) has a current Pre-Tax Income of CHF2,000 Mil. The stock's GF Value™ is CHF33.10, compared to a current price of CHF39.27 — trading 18.6% above its estimated fair value. The current Pre-Tax Income is CHF2,000 Mil. Fresenius SE KGaA's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Pre-Tax Income is CHF2,000 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued.
The current stock price of CHF39.27 is trading 18.6% above its estimated GF Value™ of CHF33.10.
Key valuation signals for XSWX:FRE:
Pre-Tax Income: CHF2,000 Mil
GF Value™: CHF33.10 vs. price of CHF39.27 (18.6% above fair value)
No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
70GF Score
Get the complete analysis for XSWX:FRE
Pre-Tax Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FRE has been successfully added to your 
